Status:
TERMINATED
A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain
Lead Sponsor:
Forest Laboratories
Collaborating Sponsors:
University of Florida
Conditions:
Chronic Pancreatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate two different treatments in subjects with chronic pancreatitis, exocrine pancreatic insufficiency and chronic abdominal pain.
Detailed Description
To evaluate two different preparations of a pancreatic enzyme in subjects with chronic pancreatitis, exocrine pancreatic insufficiency, and chronic abdominal pain.
Eligibility Criteria
Inclusion
- Diagnosis of Chronic Pancreatitis
- Exocrine Pancreatic Insufficiency
- Chronic abdominal pain
Exclusion
- Acute pancreatitis
- Active alcohol consumption
- Uncontrolled diabetes
Key Trial Info
Start Date :
August 2 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01159119
Start Date
August 2 2010
End Date
July 1 2011
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32611